Fibroblast growth factor 21 protects against cardiac hypertrophy in mice

Nature Communications

Volumn 4, Issue , 2013, Pages

  Planavila, A ^a   Redondo, I ^a   Hondares, E ^a   Vinciguerra, M ^b,c   Munts, C ^d   Iglesias, R ^a   Gabrielli, L A ^a,e   Sitges, M ^a   Giralt, M ^a   Van Bilsen, M ^d   Villarroya, F ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FIBROBLAST GROWTH FACTOR 21; ISOPRENALINE;

CARDIOVASCULAR DISEASE; CYTOLOGY; FATTY ACID; FUNCTIONAL ROLE; GLUCOSE; METABOLISM; OXIDATION; PROTEIN; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; HEART; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART PROTECTION; HEART WEIGHT; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; CARDIOTONIC AGENTS; FETUS; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; INFLAMMATION; INFLAMMATION MEDIATORS; ISOPROTERENOL; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; PHENYLEPHRINE; RATS; RNA, MESSENGER;

MUS;

EID: 84879666287     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3019     Document Type: Article

References (37)

1. van Bilsen, M., van der Vusse, G. J. & Reneman, R. S. Transcriptional regulation of metabolic processes: implications for cardiac metabolism. Pflugers Arch. 437, 2-14 (1998). (Pubitemid 29071305)
2. Smeets, P. J. et al. Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta. J. Biol. Chem. 283, 29109-29118 (2008).
3. Planavila, A., Iglesias, R., Giralt, M. & Villarroya, F. Sirt1 acts in association with PPAR{alpha} to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc. Res. 90, 276-284 (2011).
4. Fredj, S., Bescond, J., Louault, C. & Potreau, D. Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation. J. Cell Physiol. 202, 891-899 (2005). (Pubitemid 40175867)
5. Gnecchi, M. et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11, 367-368 (2005). (Pubitemid 40562318)
6. Doroudgar, S. & Glembotski, C. C. The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart. Trends Mol. Med. 17, 207-214 (2011).
7. Frost, R. J. & Engelhardt, S. A secretion trap screen in yeast identifies protease inhibitor 16 as a novel antihypertrophic protein secreted from the heart. Circulation 116, 1768-1775 (2007). (Pubitemid 350287101)
8. Stastna, M., Chimenti, I., Marban, E. & Van Eyk, J. E. Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes. Proteomics 10, 245-253 (2010).
9. Badman, M. K. et al. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell. Metab. 5, 426-437 (2007). (Pubitemid 46825495)
10. Galman, C. et al. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell. Metab. 8, 169-174 (2008).
11. Inagaki, T. et al. Endocrine regulation of the fasting response by PPARalphamediated induction of fibroblast growth factor 21. Cell. Metab. 5, 415-425 (2007). (Pubitemid 46825496)
12. Muise, E. S. et al. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol. Pharmacol. 74, 403-412 (2008).
13. Izumiya, Y. et al. FGF21 is an Akt-regulated myokine. FEBS Lett. 582, 3805-3810 (2008).
14. Hondares, E. et al. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J. Biol. Chem. 286, 12983-12990 (2011).
15. Hondares, E. et al. Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell. Metab. 11, 206-212 (2010).
16. Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627-1635 (2005). (Pubitemid 40814671)
17. Dutchak, P. A. et al. Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones. Cell 148, 556-567 (2012).
18. Kharitonenkov, A. et al. FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho. J. Cell Physiol. 215, 1-7 (2008). (Pubitemid 351363185)
19. Kurosu, H. et al. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282, 26687-26695 (2007). (Pubitemid 47501965)
20. Jin, Y. et al. Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development. J. Mol. Cell Cardiol. 26, 1449-1459 (1994). (Pubitemid 24350154)
21. Ogawa, Y. et al. BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl Acad. Sci. USA 104, 7432-7437 (2007). (Pubitemid 47185923)
22. Uebanso, T. et al. Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor? PLoS One 6, e22976 (2011).
23. Karliner, J. S. et al. Neonatal mouse cardiac myocytes exhibit cardioprotection induced by hypoxic and pharmacologic preconditioning and by transgenic overexpression of human Cu/Zn superoxide dismutase. J. Mol. Cell Cardiol. 32, 1779-1786 (2000).
24. Xu, J. et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58, 250-259 (2009).
25. Xu, J. et al. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin resistant mouse models-Association with liver and adipose tissue effects. Am. J. Physiol Endocrinol. Metab. 297, 1105-1114 (2009).
26. Liu, S. Q. et al. Cardioprotective mechanisms activated in response to myocardial ischaemia. Mol. Cell Biomech. 8, 319-338 (2011).
27. Liu, S. Q. Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia. US patent. WO 2011/006072 A2.
28. Booysen, H. L., Norton, G. R., Opie, L. H. & Woodiwiss, A. J. Reverse chamber remodelling following adrenergic-induced advanced cardiac dilatation and pump dysfunction. Basic Res. Cardiol. 107, 238 (2012).
29. Lehman, J. J. & Kelly, D. P. Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clin. Exp. Pharmacol. Physiol. 29, 339-345 (2002). (Pubitemid 34227071)
30. Schilling, J. et al. Toll-Like Receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferatoractivated receptor {gamma} coactivator-1 signaling. Circ. Heart Fail 4, 474-482 (2011).
31. Alvarez-Guardia, D. et al. The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Cardiovasc. Res. 87, 449-458 (2010).
32. Fisher, F. M. et al. FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 26, 271-281 (2012).
33. Stachowiak, E. K., Fang, X., Myers, J., Dunham, S. & Stachowiak, M. K. cAMPinduced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor-1 (FGFR1). J. Neurochem. 84, 1296-1312 (2003). (Pubitemid 36343596)
34. Ventura-Clapier, R., Garnier, A. & Veksler, V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc. Res. 79, 208-217 (2008). (Pubitemid 351951611)
35. Eisele, P. S., Salatino, S., Sobek, J., Hottiger, M. O. & Handschin, C. The PGC-1 coactivators repress the transcriptional activity of NF-kappaB in skeletal muscle cells. J. Biol. Chem. 288, 2246-2260 (2012).
36. Purushotham, A. et al. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell. Metab. 9, 327-338 (2009).
37. Amat, R. et al. SIRT1 controls the transcription of the peroxisome proliferatoractivated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD. J. Biol. Chem. 284, 21872-21880 (2009).